Watch for Tirzepatide, a New Injectable Diabetes Med
July 2022
There’s buzz about tirzepatide (Mounjaro), a new Rx injectable for type 2 diabetes.
You’ll hear that it’s the first “twincretin.”
That’s because this GLP-1/GIP agonist works in two ways to mimic incretins...hormones that help increase insulin release, decrease blood sugar, and promote fullness, especially after meals.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 200+ CE courses, including the popular CE-in-the-Letter
- Quick reference drug comparison charts
- Access to the entire archive
Already a subscriber? Log in
Volume pricing available. Get a quote